Page last updated: 2024-11-02

pirenzepine and Myotonic Disorders

pirenzepine has been researched along with Myotonic Disorders in 1 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Myotonic Disorders: Diseases characterized by MYOTONIA, which may be inherited or acquired. Myotonia may be restricted to certain muscles (e.g., intrinsic hand muscles) or occur as a generalized condition.

Research Excerpts

ExcerptRelevanceReference
"Susceptibility for malignant hyperthermia was detected by a positive in vitro contracture test."1.31[Incompatibility of olanzapine and amisulpride in multisystemic myotonic myopathy]. ( Grohmann, R; Pedrosa Gil, F; Rüther, E; Schneider, C, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pedrosa Gil, F1
Schneider, C1
Grohmann, R1
Rüther, E1

Other Studies

1 other study available for pirenzepine and Myotonic Disorders

ArticleYear
[Incompatibility of olanzapine and amisulpride in multisystemic myotonic myopathy].
    Der Nervenarzt, 2001, Volume: 72, Issue:9

    Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Creatine Kinase; Drug Interactions; Genet

2001